How SGS Supports Cell & Gene Therapy Manufacturing

The burgeoning field of Cell and Gene Therapy (CGT) holds immense promise for revolutionizing medicine. However, ensuring the safety and efficacy of these treatments necessitates rigorous quality control throughout the manufacturing process. SGS offers a dependable solution through its unparalleled suite of analytical services.

Our expertise encompasses critical quality attributes like safety, identity, potency, purity, and overall quality. We partner with you throughout the entire CGT development lifecycle, from initial development and technology transfer to stability testing and final product release. By leveraging our industry-leading biopharmaceutical testing portfolio, you gain access to unmatched capabilities in biosafety, characterization, and quality control/release.

SGS's extensive experience in biopharmaceuticals, coupled with our global network of laboratories and exceptional client service, makes us the ideal partner for all your CGT outsourcing needs. Learn how we can help you navigate the complexities of CGT development and deliver safe, efficacious therapies to patients.